Newsroom.

A new level of global insight and perspective will be offered at AusBiotech + Invest 2020, Australia’s largest life sciences conference. Australia’s biggest week in biotech is the feature event that the sector has known and trusted for 35 years, developed by industry for industry, it will be delivered online live 28 – 30 October and on-demand.

The programme is packed with more than 100 inspiring thought leaders from across the globe, in more than 40 sessions over three days. AusBiotech remains committed to providing a valuable, flexible and accessible forum to engage current and future biotech leaders to pitch, partner, exchange & engage, no matter where you are.

Global speakers include: Dr Michelle McMurry-Heath, President & CEO, Biotechnology Innovation Organisation (BIO), United States; Janet Lynch Lambert, CEO, Alliance for Regenerative Medicine (ARM) United States; Dr Reza Halse, President, MRL Ventures Fund, United States; Dr Niels Emmerich, Vice President and Global Head, Search and Evaluation, AbbVie, Inc, United States; and Dr Barbara Sosnowski, VP and Global Head of Emerging Science and Innovation Leads, Pfizer Worldwide R&D, United States.

Recognising and celebrating Australian innovation, national speakers include: Paul Brennan, Managing Director, PolyNovo Limited;  Dr Jackie Fairley AO, Chair, Invest Victoria & Chief Executive Officer, Starpharma Holdings; Dr Craig Rayner, President, Integrated Drug Development, Certara; and Professor Tanya Monro, Chief Defence Scientist, Department of Defence Science and Technology, Australian Government;

Keynotes, panel discussions and key themes will cover: The global biotech response to COVID-19; Australia’s life sciences industry uniting through COVID-19; medtech and digital health; clinical trials; global pharma talks: search, evaluation and venture investment; the business of biotech; regenerative medicine and cell therapies; therapeutics and personalised medicine; regulatory innovation; and health meets agriculture.

AusBiotech + Invest 2020 includes a student scholarship programme to recognise, encourage and upskill students of all backgrounds from across Australia. The programme aligns with its partner AbbVie’s commitment to serving the community and driving diversity and inclusion.

The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2020 will recognise and celebrate life science leaders who are championing the sector and the Australian community through the worst pandemic and greatest collaboration seen in the sector, with four new Award categories: COVID19 life science sector innovation award; COVID19 life science sector collaboration award; COVID19 communication leaders’ award; and the Industry’s choice award.

Despite the volatility and challenging market brought upon us by the pandemic, Australia’s biotechnology industry presents a compelling opportunity for investors and international partners. AusBiotech + Invest 2020 will include an investment showcase, including its leading Australia Biotech Invest & Partnering annual event, and an Early Stage Investment Forum. Private and publicly-funded companies can take centre-stage and present to an audience of investors to make meaningful connections, and early stage projects can receive direct feedback on pitches from an expert panel of investors.

Lorraine Chiroiu, CEO, AusBiotech, said, “In a year where biotechnology is demonstrating its critical worth, it’s more important than ever that we gather to progress our industry and engage. Until we can meet again in person, all your favourite features to exchange ideas, pitch, partner, and learn, will be delivered by AusBiotech and the industry, for the industry.”

Driving our industry strongly forward, the virtual conference includes a live and interactive three-day multi-stream AusBiotech + Invest 2020 programme, one-to-one partnering, and online exhibition. On demand access also allows delegates to return and view conference programme sessions, exhibition, sponsors and retrieve your notes taken during AusBiotech + Invest 2020.

AusBiotech + Invest 2020 is proudly supported by the host state partner, the Victorian Government.

Engage, no matter where you are. Register for AusBiotech + Invest 2020 here.

-ENDS-
Media enquiries: Karen Parr, Director, Communications, AusBiotech,
kparr@ausbiotech.org / P: +61 (0) 3 9828 1405 / M: +61 (0) 420 729 123

 

About AusBiotech

AusBiotech is Australia’s biotechnology organisation, working on behalf of members for more than 30 years to provide representation and services to promote the global growth of Australian biotechnology. AusBiotech is the voice of a well-connected network of over 3,000 members in the life sciences, including therapeutics, medical technology (devices and diagnostics), food technology and agricultural sectors.

Event details

Date: 28 – 30 October 2020
Venue: Online, and on demand
Website: www.ausbiotechnc.org
Programme: www.ausbiotechnc.org/programme